Acconeer: Minor short term estimate changes - Redeye

Redeye makes nothing more than minor short-term estimate changes following Acconeer's Q1 report, meaning no effect on the valuation. We believe Q1 was a turning point and that the coming easy comparables make it possible for Acconeer to report sales growth of about 100% for all remaining quarters of 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/1009916/acconeer-minor-short-term-estimate-changes?utm_source=finwire&utm_medium=RSS